The EPS miss vs consensus is likely to create near-term selling pressure, but the raised guidance and strong HSA asset growth underpin the long-term story. Watch for the conference call tone regarding HSA cash repricing dynamics and whether the massive buyback authorization provides a floor. The 90% analyst buy rating suggests consensus will focus on the non-GAAP beat and guidance raise.
Price Chart
Executive Summary
HealthEquity reported Q1 FY2027 revenue of $354.6M (+7% YoY), beating the $352.2M consensus, but GAAP EPS of $0.82 missed the $1.11 consensus estimate by 26%. The company raised fiscal 2027 guidance and authorized an additional $1.0B share repurchase, signaling confidence despite the headline EPS miss.
Key Financial Metrics
Key Facts
- Revenue of $354.6M beat consensus of $352.2M, up 7% YoY
- GAAP EPS of $0.82 missed consensus of $1.11 (non-GAAP EPS of $1.24 vs consensus N/A)
- Net income rose 29% to $69.4M, net income margin expanded to 20% from 16%
- Adjusted EBITDA grew 17% to $164.5M, margin expanded to 46% from 42%
- Total HSA assets grew 19% to $37.1B; HSAs with investments up 18%
- Board authorized $1.0B additional share repurchase; $123M spent in Q1
- Fiscal 2027 revenue guidance raised to $1.410-$1.420B; Adjusted EBITDA $625-$633M
Financial Impact
$354.6M revenue vs $352.2M consensus (+0.7% surprise); GAAP EPS $0.82 vs $1.11 consensus (-26.1% miss). Fiscal 2027 revenue guided to $1.410-$1.420B.
Risk Factors
- GAAP EPS miss of 26% vs consensus may weigh on the stock despite revenue beat
- HSA cash repricing schedule shows significant portion at low 1.8% yield through FY2027, limiting custodial revenue growth
- Rising expense base: total operating expenses grew 9% YoY, outpacing revenue growth
- Reliance on interest rate environment for custodial revenue; rate cuts could pressure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3303238 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 27, 2026 5w ago | 8-K | $93.39 $88.60 | ▼ −5.13% | ▼ −4.62% | $90.04 (−3.59%) |
Aug 27, 2026 5w ago | Press Release | $93.39 $88.60 | ▼ −5.13% | ▼ −4.62% | $90.04 (−3.59%) |
Aug 3, 2026 8w ago | Press Release | $104.97 $97.00 | ▼ −7.59% | ▼ −6.35% | $90.04 (−14.22%) |
Jun 2, 2026 17w ago | Insider Cluster | $85.21 $95.31 | ▲ +11.85% | ▲ +12.85% | $90.04 (+5.67%) |
May 28, 2026 18w ago | 8-K | $87.99 $87.81 | ▼ −0.20% | ▲ +1.59% | $90.04 (+2.33%) |
May 28, 2026 18w ago | Press Release | $87.99 $87.81 | ▼ −0.20% | ▲ +1.59% | $90.04 (+2.33%) |
May 8, 2026 21w ago | 8-K | $81.65 $89.23 | ▲ +9.28% | ▲ +9.59% | $90.04 (+10.28%) |
Mar 17, 2026 28w ago | Press Release | $79.57 $84.53 | ▲ +6.23% | ▲ +0.19% | $90.04 (+13.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access